Clinic
Uhs of Texoma, INC
Uhs of Texoma, INC was paid $12.51M by Medicaid between Jun 2018 and Dec 2024, across 91 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoUHS OF TEXOMA, INC
DENISON, TX 75020
DENISON, TX 75020
33aNPI1851390967assigned 07/20/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$12.51M
24GClaims202,923
24DCodes billed91
24AFirst – last monthJun 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#40 of 320
Median peer was paid$205K
This provider vs. median61×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24 | $3K | |
| 2019 | 31 | $6K | |
| 2020 | 4,068 | $308K | |
| 2021 | 44,242 | $2.43M | |
| 2022 | 62,812 | $3.32M | |
| 2023 | 63,561 | $4.21M | |
| 2024incomplete | 28,185 | $2.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 14,903 | 14,200 | $4.74M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 30% | 10,231 | 8,828 | $3.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 27,889 | 26,862 | $1.60M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 9,625 | 9,233 | $358K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.4% | 15,663 | 7,682 | $301K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 3,420 | 2,858 | $184K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 6,652 | 6,308 | $182K |
| 87430 | 1.3% | 8,141 | 7,936 | $162K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 9,672 | 9,262 | $161K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,045 | 14,153 | $117K |
| 59025 | Fetal non-stress test | <1% | 1,241 | 864 | $116K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 2,459 | 2,347 | $106K |
79 more codes
| 80053 | Comprehensive metabolic panel | <1% | 9,065 | $93K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,149 | $85K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 552 | $82K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 240 | $63K |
| 88142 | <1% | 1,640 | $41K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,707 | $28K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 171 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,430 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 477 | $24K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 477 | $24K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 473 | $23K |
| 76937 | <1% | 283 | $21K | |
| 83690 | <1% | 2,980 | $18K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 456 | $17K |
| 84484 | <1% | 2,286 | $17K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 343 | $16K |
| 81025 | <1% | 1,793 | $15K | |
| 81001 | <1% | 5,045 | $14K | |
| 83735 | <1% | 2,632 | $14K | |
| 83880 | <1% | 485 | $13K | |
| 87420 | <1% | 414 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,601 | $10K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,449 | $8K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 155 | $7K |
| 97597 | <1% | 148 | $7K | |
| 80076 | <1% | 629 | $6K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 12 | $4K |
| 81003 | <1% | 2,121 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,328 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,134 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,215 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 117 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,002 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 35 | $3K |
| 85610 | <1% | 1,464 | $2K | |
| 84703 | <1% | 299 | $2K | |
| 85730 | <1% | 764 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 50 | $2K |
| 84702 | <1% | 168 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 38 | $2K |
| 83605 | <1% | 228 | $1K | |
| 76801 | <1% | 15 | $1K | |
| 82565 | <1% | 376 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 29 | $1K |
| 85027 | <1% | 486 | $946.42 | |
| 87081 | <1% | 94 | $836.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 113 | $817.42 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 426 | $729.77 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 617 | $713.37 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 312 | $581.65 |
| 86901 | <1% | 363 | $558.85 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 13 | $490.31 |
| 86900 | <1% | 249 | $469.27 | |
| 87077 | <1% | 179 | $446.52 | |
| 87186 | <1% | 166 | $384.80 | |
| 87486 | <1% | 12 | $361.97 | |
| 87581 | <1% | 12 | $361.97 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 86 | $341.70 |
| 85379 | <1% | 55 | $338.97 | |
| 88304 | <1% | 13 | $205.26 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,115 | $198.48 |
| 86850 | <1% | 14 | $197.49 | |
| 82550 | <1% | 45 | $180.13 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 272 | $134.40 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $110.61 |
| 87040 | <1% | 65 | $106.39 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 167 | $60.87 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 80 | $47.86 |
| 84145 | <1% | 15 | $44.63 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 72 | $44.53 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 15 | $43.37 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 98 | $27.82 |
| 82962 | <1% | 871 | $8.31 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 55 | $0.00 |
| A9270 | Non-covered item or service | 0% | 1,330 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 40 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 16 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 12 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (CFO, SENIOR VP)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
| Friends Behavioral Health System, LP | Philadelphia, PA | $9.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.